The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Nov. 24, 2025.Novo Nordisk will start rolling out the first-ever GLP-1 pill for weight loss in the U.S. on Monday, the company announced, marking a new chapter of obesity treatment in the U.S. The drug's cash prices are among the lowest on the market, ranging from $149 to$299 per month, depending on the dose. That fuels hopes that pills could help address the longstanding affor ...